C WorldWide Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $291M | Sell |
591,542
-46,886
| -7% | -$25.4M | 6.24% | 5 |
|
|
2025
Q4 | $370M | Sell |
638,428
-112,675
| -15% | -$63.7M | 6.46% | 5 |
|
|
2025
Q3 | $364M | Sell |
751,103
-136,346
| -15% | -$63.5M | 5.61% | 6 |
|
|
2025
Q2 | $360M | Sell |
887,449
-146,214
| -14% | -$61.1M | 4.88% | 7 |
|
|
2025
Q1 | $514M | Sell |
1,033,663
-43,292
| -4% | -$23.4M | 6.38% | 4 |
|
|
2024
Q4 | $560M | Sell |
1,076,955
-83,371
| -7% | -$45.8M | 6.84% | 5 |
|
|
2024
Q3 | $718M | Sell |
1,160,326
-5,595
| -0.5% | -$3.31M | 7.45% | 1 |
|
|
2024
Q2 | $645M | Sell |
1,165,921
-21,135
| -2% | -$12.1M | 6.98% | 3 |
|
|
2024
Q1 | $690M | Sell |
1,187,056
-7,800
| -0.7% | -$4.38M | 7.86% | 3 |
|
|
2023
Q4 | $634M | Sell |
1,194,856
-134,109
| -10% | -$64.9M | 8.51% | 3 |
|
|
2023
Q3 | $673M | Sell |
1,328,965
-18,476
| -1% | -$9.85M | 9.19% | 2 |
|
|
2023
Q2 | $703M | Sell |
1,347,441
-48,798
| -3% | -$26.3M | 9.08% | 2 |
|
|
2023
Q1 | $805M | Sell |
1,396,239
-141,177
| -9% | -$79.6M | 11.02% | 1 |
|
|
2022
Q4 | $847M | Sell |
1,537,416
-12,261
| -0.8% | -$6.5M | 11.22% | 1 |
|
|
2022
Q3 | $786M | Sell |
1,549,677
-7,766
| -0.5% | -$4.35M | 10.83% | 1 |
|
|
2022
Q2 | $846M | Buy |
1,557,443
+16,150
| +1% | +$8.89M | 10.62% | 1 |
|
|
2022
Q1 | $910M | Sell |
1,541,293
-40,720
| -3% | -$23.4M | 9.92% | 2 |
|
|
2021
Q4 | $1.06B | Sell |
1,582,013
-56,049
| -3% | -$35M | 9.97% | 2 |
|
|
2021
Q3 | $936M | Sell |
1,638,062
-22,780
| -1% | -$12.5M | 9.61% | 3 |
|
|
2021
Q2 | $838M | Sell |
1,660,842
-298,417
| -15% | -$141M | 8.63% | 3 |
|
|
2021
Q1 | $894M | Sell |
1,959,259
-14,635
| -0.7% | -$6.99M | 8.75% | 3 |
|
|
2020
Q4 | $919M | Buy |
1,973,894
+35,261
| +2% | +$16.5M | 9.21% | 2 |
|
|
2020
Q3 | $856M | Sell |
1,938,633
-15,452
| -0.8% | -$6.38M | 9.63% | 2 |
|
|
2020
Q2 | $708M | Sell |
1,954,085
-46,312
| -2% | -$15.5M | 8.26% | 4 |
|
|
2020
Q1 | $567M | Sell |
2,000,397
-53,477
| -3% | -$16.9M | 7.91% | 3 |
|
|
2019
Q4 | $667M | Sell |
2,053,874
-2,831
| -0.1% | -$858K | 7.97% | 2 |
|
|
2019
Q3 | $599M | Sell |
2,056,705
-90,682
| -4% | -$26M | 7.6% | 3 |
|
|
2019
Q2 | $631M | Sell |
2,147,387
-72,916
| -3% | -$20.1M | 7.84% | 2 |
|
|
2019
Q1 | $608M | Sell |
2,220,303
-35,970
| -2% | -$8.95M | 7.71% | 2 |
|
|
2018
Q4 | $505M | Buy |
2,256,273
+14,771
| +0.7% | +$3.47M | 7.3% | 3 |
|
|
2018
Q3 | $547M | Buy |
2,241,502
+4,945
| +0.2% | +$1.14M | 7.03% | 5 |
|
|
2018
Q2 | $463M | Sell |
2,236,557
-27,387
| -1% | -$5.81M | 6.43% | 7 |
|
|
2018
Q1 | $467M | Sell |
2,263,944
-13,164
| -0.6% | -$2.76M | 7.18% | 5 |
|
|
2017
Q4 | $432M | Buy |
2,277,108
+43,368
| +2% | +$8.31M | 6.25% | 7 |
|
|
2017
Q3 | $423M | Buy |
2,233,740
+61,502
| +3% | +$11.1M | 6.01% | 7 |
|
|
2017
Q2 | $379M | Buy |
2,172,238
+222,189
| +11% | +$37.3M | 5.75% | 7 |
|
|
2017
Q1 | $300M | Buy |
1,950,049
+1,772,300
| +997% | +$271M | 5.07% | 8 |
|
|
2016
Q4 | $25.1M | Buy |
177,749
+43,597
| +32% | +$6.43M | 0.48% | 24 |
|
|
2016
Q3 | $21.3M | Buy |
134,152
+60,512
| +82% | +$9.32M | 0.38% | 30 |
|
|
2016
Q2 | $10.9M | Buy |
73,640
+69,000
| +1,487% | +$10.2M | 0.21% | 39 |
|
|
2016
Q1 | $656K | Hold |
4,640
| – | – | 0.01% | 107 |
|
|
2015
Q4 | $658K | Sell |
4,640
-3,800
| -45% | -$507K | 0.01% | 120 |
|
|
2015
Q3 | $1.03M | Buy |
8,440
+1,100
| +15% | +$143K | 0.02% | 102 |
|
|
2015
Q2 | $952K | Buy |
7,340
+6,450
| +725% | +$841K | 0.01% | 110 |
|
|
2015
Q1 | $120K | Hold |
890
| – | – | ﹤0.01% | 131 |
|
|
2014
Q4 | $112K | Buy |
890
+150
| +20% | +$18.2K | ﹤0.01% | 124 |
|
|
2014
Q3 | $90K | Buy |
+740
| New | +$90K | ﹤0.01% | 119 |
|
Other funds holding TMO
VCM
C WorldWide Group's TMO Position: Q1 2026 in Review
C WorldWide Group reduced its Thermo Fisher Scientific (TMO) stake by 7.3% in Q1 2026, selling an estimated $25.4M and leaving 591,542 shares worth $291M. The position accounts for 6.24% of the portfolio, ranked #5.
C WorldWide Group first reported a position in TMO in Q3 2014 and has held it in 47 quarters since. The position peaked at $1.06B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- C WorldWide Group held 591,542 shares of Thermo Fisher Scientific worth $291M as of Q1 2026.
- C WorldWide Group sold 46,886 Thermo Fisher Scientific shares in Q1 2026, an estimated $25.4M.
- Thermo Fisher Scientific made up 6.24% of C WorldWide Group's portfolio in Q1 2026, its #5 holding.
- C WorldWide Group first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 47 quarters since.
- C WorldWide Group's Thermo Fisher Scientific position peaked at $1.06B in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on C WorldWide Group's 13F filing for Q1 2026, filed 6 May 2026.